Columbus Macro LLC Has $649,000 Stock Position in iShares Biotechnology ETF $IBB

Columbus Macro LLC trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 79.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,842 shares of the financial services provider’s stock after selling 14,983 shares during the quarter. Columbus Macro LLC’s holdings in iShares Biotechnology ETF were worth $649,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in IBB. Fairvoy Private Wealth LLC acquired a new position in shares of iShares Biotechnology ETF in the first quarter valued at approximately $1,683,000. KFG Wealth Management LLC boosted its position in shares of iShares Biotechnology ETF by 8.1% during the 1st quarter. KFG Wealth Management LLC now owns 3,762 shares of the financial services provider’s stock worth $635,000 after acquiring an additional 282 shares in the last quarter. Kestra Private Wealth Services LLC boosted its holdings in shares of iShares Biotechnology ETF by 9.4% in the 1st quarter. Kestra Private Wealth Services LLC now owns 7,176 shares of the financial services provider’s stock valued at $1,212,000 after purchasing an additional 615 shares in the last quarter. Apella Capital LLC grew its position in iShares Biotechnology ETF by 0.6% in the first quarter. Apella Capital LLC now owns 57,940 shares of the financial services provider’s stock valued at $10,236,000 after acquiring an additional 346 shares during the last quarter. Finally, Keudell Morrison Wealth Management bought a new position in iShares Biotechnology ETF in the 1st quarter valued at approximately $209,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $187.38 on Friday. The business’s fifty day moving average is $171.45 and its 200 day moving average is $171.03. iShares Biotechnology ETF has a twelve month low of $125.70 and a twelve month high of $188.69.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were issued a dividend of $0.0238 per share. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.